• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用传统和非常规方法发现新型P2Y14激动剂和拮抗剂。

Discovery of novel P2Y14 agonist and antagonist using conventional and nonconventional methods.

作者信息

Hamel Martine, Henault Martin, Hyjazie Huda, Morin Nicolas, Bayly Christopher, Skorey Kathryn, Therien Alex G, Mancini Joseph, Brideau Christine, Kargman Stacia

机构信息

Department of Biochemistry and Molecular Biology, Merck Frosst Canada, Inc., Kirkland, Quebec, Canada.

出版信息

J Biomol Screen. 2011 Oct;16(9):1098-105. doi: 10.1177/1087057111415525. Epub 2011 Aug 5.

DOI:10.1177/1087057111415525
PMID:21821827
Abstract

P2Y14 is a member of the pyrimidinergic GPCR family. UDP-Glc has been previously shown to activate human P2Y14, whereas UDP was unable to activate the receptor. In this study, the authors used conventional and nonconventional methods to further characterize P2Y14 and its ligands. Conventional calcium mobilization and nonconventional cellular impedance functional assays revealed that UMP and UDP selectively activated HEK cells coexpressing P2Y14 and Gα(qi5). In the impedance assays, the presence of exogenous Gα(qi5) resulted in agonist-induced Gq signaling, whereas in the absence of exogenous Gα(qi5), the signal was indicative of Gi. The authors established the first P2Y14 membrane filtration binding assay using a novel optimized expression vector and [(3)H]UDP as radioligand. UDP-Glc, UMP, and UDP dose dependently inhibited [(3)H]UDP binding in the binding assay, and saturation analysis revealed that UDP bound P2Y14 with a K(D) = 10 nM and a B(max) = 110 pmol/mg. The authors screened a phosphonate library and identified compound A, which inhibited UDP-Glc-mediated calcium signaling in the fluorometric imaging plate reader assay (IC(50) = 2.3 µM) and competed for [(3)H]UDP binding in the novel binding assay with a K(i) = 1280 nM.

摘要

P2Y14是嘧啶能G蛋白偶联受体(GPCR)家族的一员。先前已证明UDP-葡萄糖(UDP-Glc)可激活人P2Y14,而UDP无法激活该受体。在本研究中,作者使用传统和非传统方法进一步表征P2Y14及其配体。传统的钙动员和非传统的细胞阻抗功能测定表明,尿苷一磷酸(UMP)和UDP选择性激活共表达P2Y14和Gα(qi5)的人胚肾(HEK)细胞。在阻抗测定中,外源性Gα(qi5)的存在导致激动剂诱导的Gq信号传导,而在没有外源性Gα(qi5)的情况下,信号表明是Gi。作者使用新型优化表达载体和[³H]UDP作为放射性配体建立了首个P2Y14膜过滤结合测定法。在结合测定中,UDP-Glc、UMP和UDP剂量依赖性地抑制[³H]UDP结合,饱和分析表明UDP以K(D)=10 nM和B(max)=110 pmol/mg的亲和力结合P2Y14。作者筛选了一个膦酸酯文库并鉴定出化合物A,其在荧光成像板读数器测定中抑制UDP-Glc介导的钙信号传导(IC(50)=2.3 µM),并在新型结合测定中以K(i)=1280 nM竞争[³H]UDP结合。

相似文献

1
Discovery of novel P2Y14 agonist and antagonist using conventional and nonconventional methods.使用传统和非常规方法发现新型P2Y14激动剂和拮抗剂。
J Biomol Screen. 2011 Oct;16(9):1098-105. doi: 10.1177/1087057111415525. Epub 2011 Aug 5.
2
The identification of 4,7-disubstituted naphthoic acid derivatives as UDP-competitive antagonists of P2Y14.鉴定 4,7-二取代萘甲酸衍生物为 UDP 竞争性 P2Y14 拮抗剂。
Bioorg Med Chem Lett. 2011 May 15;21(10):2836-9. doi: 10.1016/j.bmcl.2011.03.081. Epub 2011 Mar 31.
3
Quantification of Gi-mediated inhibition of adenylyl cyclase activity reveals that UDP is a potent agonist of the human P2Y14 receptor.对Gi介导的腺苷酸环化酶活性抑制作用的定量分析表明,UDP是人类P2Y14受体的有效激动剂。
Mol Pharmacol. 2009 Dec;76(6):1341-8. doi: 10.1124/mol.109.058578. Epub 2009 Sep 16.
4
A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils.P2Y14 受体的高亲和力选择性拮抗剂抑制人中性粒细胞的 UDP-葡萄糖刺激趋化性。
Mol Pharmacol. 2013 Jul;84(1):41-9. doi: 10.1124/mol.113.085654. Epub 2013 Apr 16.
5
UDP-glucose modulates gastric function through P2Y14 receptor-dependent and -independent mechanisms.尿苷二磷酸葡萄糖通过P2Y14受体依赖性和非依赖性机制调节胃功能。
Am J Physiol Gastrointest Liver Physiol. 2009 Apr;296(4):G923-30. doi: 10.1152/ajpgi.90363.2008. Epub 2009 Jan 22.
6
Functional expression of the P2Y14 receptor in human neutrophils.P2Y14受体在人中性粒细胞中的功能表达。
Eur J Pharmacol. 2006 Aug 14;543(1-3):166-73. doi: 10.1016/j.ejphar.2006.05.037. Epub 2006 Jun 7.
7
UDP is a competitive antagonist at the human P2Y14 receptor.UDP是人类P2Y14受体的竞争性拮抗剂。
J Pharmacol Exp Ther. 2008 May;325(2):588-94. doi: 10.1124/jpet.108.136309. Epub 2008 Feb 5.
8
Pharmacological effects mediated by UDP-glucose that are independent of P2Y14 receptor expression.由UDP-葡萄糖介导的、独立于P2Y14受体表达的药理作用。
Pharmacol Res. 2005 Jun;51(6):533-8. doi: 10.1016/j.phrs.2005.02.001.
9
UDP-sugars activate P2Y receptors to mediate vasoconstriction of the porcine coronary artery.UDP-糖激活 P2Y 受体介导猪冠状动脉收缩。
Vascul Pharmacol. 2018 Apr;103-105:36-46. doi: 10.1016/j.vph.2017.12.063. Epub 2017 Dec 15.
10
Pharmacological profiles of cloned mammalian P2Y-receptor subtypes.克隆的哺乳动物P2Y受体亚型的药理学特征。
Pharmacol Ther. 2006 Jun;110(3):415-32. doi: 10.1016/j.pharmthera.2005.08.014. Epub 2005 Oct 28.

引用本文的文献

1
Identification of a carbohydrate recognition motif of purinergic receptors.鉴定嘌呤能受体的碳水化合物识别基序。
Elife. 2023 Nov 13;12:e85449. doi: 10.7554/eLife.85449.
2
Alicyclic Ring Size Variation of 4-Phenyl-2-naphthoic Acid Derivatives as P2Y Receptor Antagonists.作为 P2Y 受体拮抗剂的 4-苯基-2-萘甲酸衍生物中环大小的变化。
J Med Chem. 2023 Jul 13;66(13):9076-9094. doi: 10.1021/acs.jmedchem.3c00664. Epub 2023 Jun 29.
3
Structure-Activity Relationship of Heterocyclic P2Y Receptor Antagonists: Removal of the Zwitterionic Character with Piperidine Bioisosteres.
杂环 P2Y 受体拮抗剂的构效关系:用哌啶生物等排体去除两性离子特征。
J Med Chem. 2021 Apr 22;64(8):5099-5122. doi: 10.1021/acs.jmedchem.1c00164. Epub 2021 Mar 31.
4
Nucleoside 5'-O-monophosphorothioates as modulators of the P2Y14 receptor and mast cell degranulation.5'-硫代磷酸核苷作为P2Y14受体调节剂及肥大细胞脱颗粒的调节剂
Oncotarget. 2016 Oct 25;7(43):69358-69370. doi: 10.18632/oncotarget.12541.
5
UDP-Sugars as Extracellular Signaling Molecules: Cellular and Physiologic Consequences of P2Y14 Receptor Activation.UDP-糖作为细胞外信号分子:P2Y14受体激活的细胞和生理后果
Mol Pharmacol. 2015 Jul;88(1):151-60. doi: 10.1124/mol.115.098756. Epub 2015 Mar 31.
6
The G protein-coupled receptor P2Y14 influences insulin release and smooth muscle function in mice.G蛋白偶联受体P2Y14影响小鼠的胰岛素释放和平滑肌功能。
J Biol Chem. 2014 Aug 22;289(34):23353-66. doi: 10.1074/jbc.M114.580803. Epub 2014 Jul 3.
7
Co-expression of VAL- and TMT-opsins uncovers ancient photosensory interneurons and motorneurons in the vertebrate brain.VAL 和 TMT 视蛋白的共表达揭示了脊椎动物大脑中的古老感光中间神经元和运动神经元。
PLoS Biol. 2013;11(6):e1001585. doi: 10.1371/journal.pbio.1001585. Epub 2013 Jun 11.
8
A selective high-affinity antagonist of the P2Y14 receptor inhibits UDP-glucose-stimulated chemotaxis of human neutrophils.P2Y14 受体的高亲和力选择性拮抗剂抑制人中性粒细胞的 UDP-葡萄糖刺激趋化性。
Mol Pharmacol. 2013 Jul;84(1):41-9. doi: 10.1124/mol.113.085654. Epub 2013 Apr 16.